A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects

NCT06126562 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetic

Interventions

DRUG: Lanifibranor

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.